Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Sibylla Biotech Appoints Usman Azam as Chief Executive Officer and Gianluca Fuggetta as Chief Financial Officer

PRIVATEOct 13, 2026
New to company · from CUE Biopharma“Dr. Azam most recently served as Chief Executive Officer of CUE Biopharma”

Position

Chief Financial Officer

Company

Sibylla Biotech

Gianluca Fuggetta
BressoManufacturingBiotechnologyFood And Beverage

Description

Sibylla Biotech has announced the appointment of Usman Azam as Chief Executive Officer and Gianluca Fuggetta as Chief Financial Officer. Lidia Pieri will continue as Chief Operating Officer, and Elena Ardini has been promoted to Chief Scientific Officer. This expansion of the executive leadership team is aimed at accelerating the development of Sibylla’s oncology pipeline.

Company Information

Company

Sibylla Biotech

Location

Via Dei Solteri

Bresso, Lombardy, Italy

About

Sibylla is disrupting the protein degradation landscape by applying a novel mechanism of action that interferes with protein folding and thereby suppresses the expression of a disease-relevant protein. Through their protein folding simulation technology platform, Sibylla identifies relevant and previously inexplorable folding intermediates for protein targets that are currently considered undruggable in their native state. The company is developing a proprietary pipeline of small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.

Fundz sees it the moment Sibylla Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sonia
Likely contact at this company
••••••••@••••••••

See Sonia's verified email →

Usman
Likely contact at this company
••••••••@••••••••

See Usman's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Sibylla Biotech's next move

Learn about Strategic plan

Sibylla Biotech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.